---
title: "Modern Chinese Medicine Flags High Shareholding Concentration After Sharp Price Surge"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282721009.md"
description: "Modern Chinese Medicine Group Co. Ltd. (HK:1643) announced a high concentration of shareholding, with 25 shareholders holding 90.6% of issued shares as of March 30, 2026. This raises concerns about market depth and trading dynamics. The company's share price surged 316% from HK$0.51 at the end of 2025 to HK$2.12 by March 30, 2026, and further to HK$2.94 by April 13, 2026. While the board meets the public float requirement, it warns of potential price volatility due to the concentrated shareholding, advising investors to exercise caution."
datetime: "2026-04-14T15:09:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282721009.md)
  - [en](https://longbridge.com/en/news/282721009.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282721009.md)
---

# Modern Chinese Medicine Flags High Shareholding Concentration After Sharp Price Surge

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ) has shared an announcement.

Modern Chinese Medicine Group Co., Ltd. has disclosed that the Securities and Futures Commission found a high concentration of its shares among 25 shareholders and related parties as of 30 March 2026, who collectively held 90.6% of the issued share capital. This leaves just 9.4% of shares in the hands of other investors, raising concerns about trading dynamics and market depth.

During the same period, the company’s share price surged sharply, rising 316% from HK$0.51 at the end of 2025 to HK$2.12 on 30 March 2026, and further to HK$2.94 by 13 April 2026, a 476% increase from year-end 2025. While the board confirms it continues to meet the Hong Kong public float requirement of at least 25%, it warns that the high shareholding concentration could lead to substantial price volatility on relatively small trading volumes and may limit the existence of a genuine market in the stock, urging investors to exercise extreme caution.

**More about Modern Chinese Medicine Group Co. Ltd.**

Modern Chinese Medicine Group Co., Ltd., incorporated in the Cayman Islands and listed in Hong Kong under stock code 1643, operates in the pharmaceutical and healthcare sector with a focus on modern Chinese medicine. The company serves investors in the Hong Kong equity market and is subject to the city’s securities and listing regulations.

**Average Trading Volume:** 3,081,203

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$2.17B

### Related Stocks

- [01643.HK](https://longbridge.com/en/quote/01643.HK.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)

## Related News & Research

- [RemeGen says SPDB wealth product disclosure delay stems from oversight, sets remedial steps](https://longbridge.com/en/news/286916188.md)
- [Modern Chinese Medicine Group Wins Waiver for Delay in Acquisition Circular](https://longbridge.com/en/news/285533413.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [FRONTERA ANNOUNCES FIRST QUARTER 2026 RESULTS | FECCF Stock News](https://longbridge.com/en/news/286507909.md)
- [Crombie Reit Announces May 2026 Monthly Distribution | CROMF Stock News](https://longbridge.com/en/news/286603129.md)